HOME >> BIOLOGY >> NEWS
High-tech institute to hold Cal-(IT)Day@UCSD

new materials and devices; medical technologies and bioinformatics; automotive telematics; networking; wireless and optical communications; new media arts and visualization; culture, art and technology in education; and geosciences. The conference will also feature a panel of senior officials from state and federal agencies that are funding Cal-(IT)2 projects.

Organizers have also arranged the day's events to permit maximum interaction between Cal-(IT)2 participants, partners and visitors from corporations, local government, and funding agencies. The afternoon session will end with a roundtable discussion among UCSD deans, moderated by Cal-(IT)2 director Larry Smarr, about the future of the research university -- and the role that interdisciplinary institutes such as Cal-(IT)2 will play. Added Rao: "This event will provide an opportunity to share with current and potential UCSD industry sponsors our success in leveraging corporate support to obtain additional funding."

There is no fee to participate in Cal-(IT)2Day@UCSD, and the event is open to the public. Attendees are asked to pre-register online at www.calit2.net/calit2day. For more information about the institute, go to www.calit2.net. Association Sponsors for this event include the San Diego Telecom Council (www.sdtelecom.org), San Diego Regional Chamber of Commerce (www.sdchamber.org), BIOCOM (www.biocom.org), and San Diego Software Industry Council (www.sdsic.org).


'"/>

Contact: Doug Ramsey
dramsey@ucsd.edu
858-822-5825
University of California - San Diego
25-Aug-2003


Page: 1 2

Related biology news :

1. High-tech analysis of vineyard soil
2. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
3. Maine-based biophysics institute gets funding for first US-based 4Pi nanoscale microscope
4. Genomic biology institutes first grant to focus on soybeans, climate change
5. Weizmann institute scientists solve the 3-D structure of the enzyme involved in Gaucher disease
6. Lab, OSU join in new microproducts institute
7. UCLA and NASA partner to form new institute for Cell Mimetic Space Exploration
8. Stanford receives funding for unique cancer and stem cell biology institute
9. New NSF institutes to strengthen mathematics as base for national S&T
10. Regenerative medicine to be focus of new institute at University of Pittsburgh School of Medicine and UPMC Health System
11. With first comparative look at human and mouse DNA, joint genome institute team confirms gene estimate

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: High tech institute hold Cal Day UCSD

(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
(Date:4/21/2015)... 21, 2015 High crime ... are boosting access control systems market in ... a recently published report by TechSci Research " Saudi ... access control systems market in Saudi Arabia ... 2020.The access control systems market in the Kingdom is ...
(Date:4/14/2015)... Conn. , April 14, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... been nominated for the 2015 New York Design Awards ... The Design100, New York City Design Awards are part ... based on over 2,500 ratings from the marketplace, industry ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
(Date:5/22/2015)... 2015 Knowledgent , the data ... explores the potential of big data analytics in the ... developed to help life sciences and healthcare organizations understand ... gain critical business insights. , The life sciences and ... driven by patient profiling, compliance and regulatory requirements, and ...
(Date:5/21/2015)... Specialty Pharmacy Times has completed ... to BPA Worldwide as a business publication member. ... data for Specialty Pharmacy Times based on business/distribution, ... a member of BPA Worldwide, Specialty Pharmacy Times ... with the most reliable, unequaled data,” said Chris ...
(Date:5/21/2015)... May 21, 2015  The EveryLife Foundation for ... (R-UT) and Amy Klobuchar (D-MN) today ... Cures & Treatments, or OPEN ACT. ... advocacy organizations, this bipartisan legislation promises to rapidly ... to rare disease patients by incentivizing drug makers ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
Breaking Biology Technology:New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2Specialty Pharmacy Times Joins BPA Worldwide 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7
Cached News: